Eli Lilly, the maker of hugely popular weight loss drugs, has reached $1 trillion in value, becoming the first publicly ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

It’s just the latest landmark for Indianapolis-based Lilly, which was catapulted into the top spot as the world’s largest ...

Once-a-day pill could offer a cheaper alternative to weight loss jabs - About 2.5million people in the UK use GLP-1 drugs for ...

Weight-loss drugs like Wegovy and Zepbound often cause nausea and other side effects. Brain scientists are looking for ways ...

A new oral GLP-1 medication can help adults with obesity and Type 2 diabetes lose more weight and improve their blood sugar ...

State Representative Erin Byrnes, D-Dearborn, introduced a bill to give the Board of Pharmacy the power to create a list of ...

Trial participants who used eloralintide, a new weight loss medication that, instead of focusing on the hormone GLP-1, ...

Orforglipron is a small‑molecule, nonpeptide GLP‑1 receptor agonist taken once daily, and it skips some of the hassles that ...

A daily pill that is cheaper and easier to take than currently available weight loss drugs helps people lose around a tenth ...

Orforglipron, a GLP-1 drug taken as a pill, achieved positive results in people with obesity and type 2 diabetes, although it ...

The once-a-day pill belongs to class of medications called GLP-1 agonists, like Mounjaro, which suppress appetite and make ...